Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.32M Buy
1,755
+215
+14% +$295K 0.17% 110
2025
Q4
$1.65M Buy
1,540
+51
+3% +$53.2K 0.12% 139
2025
Q3
$1.44M Buy
1,489
+239
+19% +$188K 0.11% 150
2025
Q2
$864K Buy
1,250
+290
+30% +$208K 0.08% 191
2025
Q1
$650K Buy
960
+70
+8% +$50.9K 0.07% 214
2024
Q4
$651K Sell
890
-505
-36% -$363K 0.07% 217
2024
Q3
$989K Sell
1,395
-501
-26% -$448K 0.12% 152
2024
Q2
$1.59M Buy
1,896
+144
+8% +$138K 0.23% 84
2024
Q1
$1.7M Buy
1,752
+553
+46% +$491K 0.26% 78
2023
Q4
$908K Buy
1,199
+518
+76% +$342K 0.2% 103
2023
Q3
$401K Buy
681
+285
+72% +$189K 0.14% 156
2023
Q2
$287K Buy
396
+53
+15% +$36K 0.1% 205
2023
Q1
$223K Buy
+343
New +$220K 0.09% 220

Other funds holding ASML

Fidelis Capital Partners's ASML Position: Q1 2026 in Review

Fidelis Capital Partners increased its ASML (ASML) stake by 14% in Q1 2026, buying an estimated $295K and bringing the position to 1,755 shares worth $2.32M. The position accounts for 0.17% of the portfolio, ranked #110.

Fidelis Capital Partners first reported a position in ASML in Q1 2023 and has held it in 13 quarters since. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Fidelis Capital Partners held 1,755 shares of ASML worth $2.32M as of Q1 2026.
  • Fidelis Capital Partners bought 215 ASML shares in Q1 2026, an estimated $295K.
  • ASML made up 0.17% of Fidelis Capital Partners's portfolio in Q1 2026, its #110 holding.
  • Fidelis Capital Partners first reported a position in ASML in Q1 2023 and has held it in 13 quarters since.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.